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Admission rates, Healthcare utilization, and 
economic burden of radiation cystitis (RC) in the 
United States
Sohrab Arora*, Chandler Bronkema, Akshay Sood, Deepansh Dalela, Alex Borchert, Lee 
Baumgarten, Detroit, MI, Quoc-Dien Trinh, Boston, MA, Craig G. Rogers, James O. 
Peabody, Mani Menon, Firas Abdollah, Detroit, MI
• Radiation cystitis
• Major cause of morbidity after radiotherapy for pelvic cancers.
• might be a more frequent problem than previously thought, 
• Consisting of 1.4% of all elective admissions to a Urology; 
• Many patients never admitted to urology
• Presentation beyond the follow up of clinical trials
• actual prevalence not known.
• No definitive cure
• Repeated admission to inpatient care, often undergoing 
multiple urological procedures for management of hematuria. 
• Intractable cases may require morbid procedures like 
cystectomy!!
• Scanty funding for research
Introduction
Methods
• Included: 21,157 records of adult patients with a 
diagnosis of RC within the NIS from 2003-2014.
• Excluded: Concurrent diagnosis of bladder 
cancer, CIS, or tuberculosis of bladder  
(n=1,422), leaving 19,613 records for analysis 
(population estimate 94,434 per NIS survey 
weights).
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• Receipt of any inpatient procedure during admission, 
• number of inpatient procedures received (0, 1, 2, >2), 
• length of stay, 
• disposition of patient at discharge, 
• total inflation-adjusted total cost of admission, and 
• high total cost (upper quartile of inflation-adjusted cost). 
• Cost for each admission and cumulative annual cost of RC-associated 
admissions were calculated for the study period.
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Results
• Median age 75.7 years.
• The inflation-adjusted cost per admission was 9207 US 
dollars (IQR 5275 -17,573) 
• 90% of the admissions were in hospitals located in urban 
areas.
• 61.2% patients received at least one inpatient procedure. 
43% of admissions recorded more than one RC-directed 
procedure code.
• Median length of stay 4.5 days
• The cumulative cost of inpatient treatment of radiation 
cystitis was 63.5 million US dollars per year, amounting to 
a total of 952.2 million over the study period.
• Radical cystectomy was done in 1.3% of the admissions.
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Conclusion
• Disease of the elderly
• RC associated admissions are costly. About 2/3rd of the patients require 
procedures, 43% requiring more than one procedure.
• Major economic burden to US healthcare.
• No definitive treatment available
• Funding implications.
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